Crnx stock.

Struthers Richard Scott, President & CEO, Director at Crinetics Pharmaceuticals (CRNX), has a 75.00% success rate when buying and selling stocks. Top Stocks. Top Analyst Stocks Top Smart Score Stocks Top Insiders Stocks. Popular. Stock Screener Top Online Growth Stocks Trending Stocks Penny Stock Screener Newsletter Center.What's Happening With CRNX Stock Today? Crinetics Pharmaceuticals Inc (CRNX) stock is trading at $30.97 as of 11:42 AM on Monday, Nov 6, an increase of $0.27, or 0.88% from the previous closing price of $30.70. The stock has traded between $30.57 and $31.30 so far today. Volume today is low. So far 256,539 shares have traded compared to average ...Compare Stocks Compare ETFs Trending Stocks Technical Analysis Screener Penny Stock Screener Daily Analyst Ratings Daily Insider Trading Tracker. Calendars. Earnings Calendar Dividend Calendar Economic Calendar …What's Happening with CRNX Stock Today. Crinetics Pharmaceuticals Inc (CRNX) stock is higher by 0.62% while the S&P 500 is lower by -0.24% as of 12:34 PM on Thursday, Nov 30. CRNX has gained $0.20 from the previous closing price of $32.03 on volume of 314,461 shares. Over the past year the S&P 500 is higher by 11.26% while …

Crinetics Pharmaceuticals (CRNX) has priced an upsized underwritten public offering of 11.44 million shares of its common stock at a price to the public of $30.59/share.Its...

Read more to see an overview and analysis of CRNX stock. ... The stock currently trades just under $32.00 a share and sports an approximate market capitalization of $2.1 billion.

Find real-time CRNX - Crinetics Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. US22663K1079. Crinetics Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its product candidate, CRN00808, is an oral nonpeptide somatostatin agonist for the treatment of acromegaly.Complete Century Aluminum Co. stock information by Barron's. View real-time CENX stock price and news, along with industry-best analysis.Top Analyst Stocks Top Smart Score Stocks Top Insiders Stocks. Popular. Stock Screener Top Online Growth Stocks Trending Stocks Penny Stock Screener. Dividend Investing. Dividend Calculator Dividend Yield Calculator Dividend Stocks Dividend News Dividend Calendar. ETFs. ETF Center Compare ETFs SPY ETF.

According to the issued ratings of 2 analysts in the last year, the consensus rating for Century Aluminum stock is Reduce based on the current 1 sell rating and 1 hold rating for CENX. The average twelve-month price prediction for Century Aluminum is $7.50 with a high price target of $9.00 and a low price target of $6.00.

You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CRNX scored across 33 valuation, financial, forecast, performance, and dividend due ...

About Price and Consensus. The Price and Consensus chart displays the company's stock price along with the consensus estimate. Zacks tracks individual sell-side analyst estimates and creates a ...Dec 1, 2023 · According to the issued ratings of 2 analysts in the last year, the consensus rating for Century Aluminum stock is Reduce based on the current 1 sell rating and 1 hold rating for CENX. The average twelve-month price prediction for Century Aluminum is $7.50 with a high price target of $9.00 and a low price target of $6.00. Ticker Symbol: CRNX: Exchange: NASDAQ: Fiscal Year: January - December: Reporting Currency: USD: CIK Code: 0001658247: CUSIP Number: 22663K107: ISIN Number: US22663K1079Track Crinetics Pharmaceuticals Inc (CRNX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors Get the latest stock quote, news, history and other vital information to help you with your stock trading and investing in Crinetics Pharmaceuticals, Inc. (CRNX). See the performance outlook, earnings date, dividend yield, insider transactions and more. 8 brokers have issued twelve-month target prices for Crinetics Pharmaceuticals' shares. Their CRNX share price targets range from $33.00 to $56.00. On average, they predict the company's stock price to reach $45.71 in the next twelve months. This suggests a possible upside of 53.5% from the stock's current price.At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Crinetics Pharmaceuticals (CRNX) Investor Relations – Press releases, events, financials / SEC filings, corporate governance, FAQ, stock quote chart, contact information for stock holders, financial analysts, and investors.60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share.Complete Crinetics Pharmaceuticals Inc. stock information by Barron's. View real-time CRNX stock price and news, along with industry-best analysis. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements. Close Trending Tickers bar Crinetics Pharmaceuticals press release (NASDAQ:CRNX): Q3 GAAP EPS of -$1.01 misses by $0.15.; Revenue of $0.35M (-23.9% Y/Y) beats by $0.21M. Unrestricted cash, cash equivalents, and investments ...

Within the last quarter, Crinetics Pharmaceuticals (NASDAQ:CRNX) has observed the following analyst ratings: These 11 analysts have an average price target of $40.73 versus the current price of ...

On November 7, 2023, Crinetics Pharmaceuticals Inc ( NASDAQ:CRNX) released its financial results for the third quarter ended September 30, 2023. The company has reported significant clinical ...View Concentrix Corporation CNXC investment & stock information. Get the latest Concentrix Corporation CNXC detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.Crinetics Pharmaceuticals Inc’s Stock Price as of Market Close. As of November 17, 2023, 4:00 PM, CST, Crinetics Pharmaceuticals Inc’s stock price was $29.99. Crinetics Pharmaceuticals Inc is up 5.82% from its previous closing price of $28.34. During the last market session, Crinetics Pharmaceuticals Inc’s stock traded between $27.55 and ...CRNX Stock Summary. The capital turnover (annual revenue relative to shareholder's equity) for CRNX is 0.01 -- better than merely 9.38% of US stocks. CRNX's price/sales ratio is 380.96; that's higher than the P/S ratio of 98.95% of US stocks. With a year-over-year growth in debt of 1,470.47%, CRINETICS PHARMACEUTICALS INC's debt growth rate ...CRNX has gained $0.09 from the previous closing price of $28.69 on volume of 163,785 shares. Over the past year the S&P 500 has risen 16.50% while CRNX has gained 57.61%. CRNX lost -$3.41 per share the over the last 12 months. Click Here to get the full Stock Report for Crinetics Pharmaceuticals Inc stock.Kaiser Aluminum Corp. -0.89%. $892.49M. Tredegar Corp. -0.90%. $151.64M. CENX | Complete Century Aluminum Co. stock news by MarketWatch. View real-time stock prices and stock quotes for a full ...CRNX Stock Price Analysis: November 8, 2023 – Fluctuations, Low Volume, and Market Cap. On November 8, 2023, CRNX stock opened at $28.56, lower than the previous day’s closing price of $29.48. Throughout the day, the stock’s price fluctuated between a low of $27.01 and a high of $29.48. The trading volume for the day was 52,552 shares ...Dec 4, 2023 · CRNX Stock Performance on December 4, 2023: Mixed Results and Financial Metrics Analysis On December 4, 2023, CRNX stock experienced mixed performances based on the available information. The net income for CRNX over the past year was -$163.92 million and -$57.46 million in the third quarter, representing a significant decrease compared to ...

Find real-time CRNX - Crinetics Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business.

Nov 6, 2023 · What's Happening With CRNX Stock Today? Crinetics Pharmaceuticals Inc (CRNX) stock is trading at $30.97 as of 11:42 AM on Monday, Nov 6, an increase of $0.27, or 0.88% from the previous closing price of $30.70. The stock has traded between $30.57 and $31.30 so far today. Volume today is low. So far 256,539 shares have traded compared to average ...

Get Our Latest Research Report on CRNX. Crinetics Pharmaceuticals Stock Performance. Shares of CRNX opened at $32.03 on Thursday. Crinetics Pharmaceuticals has a 52-week low of $15.23 and a 52 ...CRNX has gained $0.09 from the previous closing price of $28.69 on volume of 163,785 shares. Over the past year the S&P 500 has risen 16.50% while CRNX has gained 57.61%. CRNX lost -$3.41 per share the over the last 12 months. Click Here to get the full Stock Report for Crinetics Pharmaceuticals Inc stock.Consider these seven speculative stocks for high-risk/high-reward plays. Crinetics Pharmaceuticals ( CRNX ): CRNX stock has already spiked on promising news, but there may be room for another ...Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get...We would like to show you a description here but the site won’t allow us.Century Aluminum Co. is a producer of aluminum and operates aluminum reduction facilities, or smelters, in the United States and Iceland. Its products include standard ingots, T-ingot, extrusion ...The three major U.S. stock exchanges are the New York Stock Exchange (NYSE), the NASDAQ and the American Stock Exchange (AMEX). As of 2014, the NYSE is the largest and most prestigious of the three. The NASDAQ is a virtual stock exchange.Century Aluminum Company stock price (CENX) NASDAQ: CENX. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Century Aluminum Company stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting.The stock opened at $30.37, slightly higher than the previous close of $29.97. Throughout the day, the stock reached a high of $31.21 and a low of $30.11. The trading volume for the day was 9,630 shares. CRNX, also known as IDYA Biosciences Inc., operates in the health technology sector, specifically in the major pharmaceuticals industry.Crinetics Pharmaceuticals Inc’s Stock Price as of Market Close. As of November 13, 2023, 4:00 PM, CST, Crinetics Pharmaceuticals Inc’s stock price was $28.28. Crinetics Pharmaceuticals Inc is up 5.01% from its previous closing price of $26.93. During the last market session, Crinetics Pharmaceuticals Inc’s stock traded between $25.75 and ...

CRNX stock is up 64% as of Monday morning as some 1.6 million shares change hands. The company’s daily average trading volume is about 493,000 shares. Investors seeking out even more of the most ...Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) 31.79 Delayed Data As of Nov 30 -0.24 / -0.75% Today’s Change 15.23 Today ||| 52-Week Range 32.94 +73.72% Year-to-Date …Get the latest stock quote, news, history and other vital information to help you with your stock trading and investing in Crinetics Pharmaceuticals, Inc. (CRNX). See the performance outlook, earnings date, dividend yield, insider transactions and more.Instagram:https://instagram. zoom pricewe stock forecastsuunf stock priceinsperity inc Track Crinetics Pharmaceuticals Inc (CRNX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors Nov 9, 2023 · The stock of Crinetics Pharmaceuticals Inc (CRNX) has seen a -3.72% decrease in the past week, with a 5.49% gain in the past month, and a 69.45% flourish in the past quarter. The volatility ratio for the week is 6.32%, and the volatility levels for the past 30 days are at 5.47% for CRNX. The simple. webull options applicationquarters of value According to 2 analysts, the average rating for CENX stock is "Sell." The 12-month stock price forecast is $7.5, which is a decrease of -4.58% from the latest price. Price TargetThat includes why shares of Tenon Medical (NASDAQ: TNON) stock, Versus Systems (NASDAQ: VS) stock, and Crinetics Pharmaceuticals (NASDAQ: CRNX) stock are on the move today. All of that news is ... paper trade stocks We would like to show you a description here but the site won’t allow us.Crinetics Pharmaceuticals Inc (CRNX) stock is trading at $29.24 as of 11:51 AM on Friday, Oct 27, a gain of $0.02, or 0.05% from the previous closing price of $29.22. Volume today is light. So far 195,596 shares have traded compared to average volume of 1,062,362 shares. The stock has traded between $28.52 and $29.94 so far today.